Certara
Certara, a consultancy advising on drug development and safety, has appointed Edmundo Muniz as CEO.
Muniz joins the company from Kiraz Corporation, where has has been president and CEO for nine years. He has also held positions at Eli Lilly, including Head of Worldwide Pharmacovigilance and Epidemiology, Cardiovascular Business Unit Leader, and VP of Oncology Clinical Development.
Certara’s Chairman Donald Deieso welcomed Muniz’s experience: “Edmundo is ideally suited to lead Certara. As a senior R&D executive and CEO, he has managed exactly the problems that Certara’s technology-enabled drug development and safety solutions address.”